Nieves Martinez Lago, Specialist in the Field of Medical Oncology at University Hospital Complex of Santiago de Compostela, shared an update from María San Román, Medical Oncologist at Hospital 12 de Octubre, on X, adding:
“Proud to be a co-author of this ESMO26 study from Grupo GETNE!
R-GETNE: 191 patients from 37 centres. Tumor differentiation, Ki-67 and metastatic patterns are key prognostic factors in advanced gastric NENs.
Congratulations to María San Román and the entire team for this collaborative effort!”
Quoting María San Román:
“Proud to present our ESMO26 poster.
Advanced gastric NENs from R-GETNE (n=191, 37 centres):
- NET vs NEC: mOS 50 vs 9 mo (HR 3.39)
- NETs: Ki-67 rules, mOS 66 – 34 – 10 mo (G1 – G2-high – G3)
- NECs: lung mets – mOS 4 vs 10 mo
Thanks to all co-authors and Grupo GETNE.”
This also can be interesting:
CLARITY-Gastric 01 at ESMO 2026: Sonesitatug Vedotin in CLDN18.2-Positive Gastroesophageal Cancer
